Cited by 106Dementia and Cognitive Impairment ResearchCancer-related cognitive impairment studiesAlzheimer's disease research and treatments

Expected and diagnosed rates of mild cognitive impairment and dementia in the U.S. Medicare population: observational analysis

Open access
Mattke, Soeren, Jun, Hankyung, Chen, Emily, Liu, Ying, Becker, Andrew, Wallick, Christopher·2023·Alzheimer's Research & Therapy

Abstract

Background: With the emergence of disease-modifying Alzheimer’s treatments, timely detection of early-stage disease is more important than ever, as the treatment will not be indicated for later stages. Contemporary population-level data for detection rates of mild cognitive impairment (MCI), the stage at which treatment would ideally start, are lacking, and detection rates for dementia are only available for subsets of the Medicare population. We sought to compare documented diagnosis rates of MCI and dementia in the full Medicare population with expected rates based on a predictive model. Methods: We performed an observational analysis of Medicare beneficiaries aged 65 and older with a near-continuous enrollment over a 3-year observation window or until death using 100% of the Medicare fee-for-service or Medicare Advantage Plans beneficiaries from 2015 to 2019. Actual diagnoses for MCI and dementia were derived from ICD-10 codes documented in those data. We used the 2000–2016 data of the Health and Retirement Study to develop a prediction model for expected diagnoses for the included population. The ratios between actually diagnosed cases of MCI and dementia over number of cases expected, the observed over expected ratio, reflects the detection rate. Results: Although detection rates for MCI cases increased from 2015 to 2019 (0.062 to 0.079), the results mean that 7.4 of 8 million (92%) expected MCI cases remained undiagnosed. The detection rate for MCI was 0.039 and 0.048 in Black and Hispanic beneficiaries, respectively, compared with 0.098 in non-Hispanic White beneficiaries. Individuals dually eligible for Medicare and Medicaid had lower estimated detection rates than their Medicare-only counterparts for MCI (0.056 vs 0.085). Dementia was diagnosed more frequently than expected (1.086 to 1.104) from 2015 to 2019, mostly in non-Hispanic White beneficiaries (1.367) compared with 0.696 in Black beneficiaries and 0.758 in Hispanic beneficiaries. Conclusions: These results highlight the need to increase the overall detection rates of MCI and of dementia particularly in socioeconomically disadvantaged groups.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13195-023-01272-z

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • There may be as many as 8 million people with undiagnosed MCI.

    “suggesting there may be as many as 8 million people with undiagnosed MCI”

    From 2024 Alzheimer's disease facts and figures (2024) · cites this paper as [696]

  • A recent study of Medicare beneficiaries found that only about 8% of expected mild cognitive impairment (MCI) cases are diagnosed on average.

    “A recent study of Medicare beneficiaries found that only about 8% of expected mild cognitive impairment (MCI) cases are diagnosed on average, suggesting there may be as many as 8 million people with undiagnosed MCI”

    From 2024 Alzheimer's disease facts and figures (2024) · cites this paper as [696]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Mattke, S., Jun, H., Chen, E., Liu, Y., Becker, A., & Wallick, C.
Affiliations
  • University of Southern California (US)
  • Harvard University (US)
  • Roche (United States) (US)
Corresponding author
Mattke, Soeren
Venue
Alzheimer's Research & Therapy
Published
2023-07-22
Volume
15
Issue
1
Pages
128-128
ISSN
1758-9193 (ISSN-L)
OpenAlex
W4385075320
Cited by
106
References
38
Citations by year
2026: 32 · 2025: 39 · 2024: 32 · 2023: 3
FWCI
21.59
Type
journal article
Language
en
Open access
Locations
  • Alzheimer s Research & Therapy (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Genentech, Inc., a member of the Roche Group
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cancer-related cognitive impairment studies
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
Keywords
mild cognitive impairment, dementia, detection rate, underdiagnosis, Medicare beneficiaries, older adults, racial and ethnic disparities, prediction model, ICD-10 diagnoses
MeSH terms
Aged, Alzheimer Disease, Medicare, Humans, United States, Cognitive Dysfunction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review